Key result
Higher HDL-C linked to ~1% lower stroke risk, partially mediated by BMI.
Why the study?
Do higher HDL-C levels reduce the risk of stroke and all-cause mortality in a middle-aged and older Chinese population?
Cohort (n=6,090)
Yes
Do higher HDL-C levels reduce the risk of stroke and all-cause mortality in a middle-aged and older Chinese population?
Higher HDL-C levels are associated with a slightly reduced risk of incident stroke, partially mediated by BMI, but not with all-cause mortality in middle-aged and older Chinese adults.
Answers are grounded in this paper and cite their sources.
Should not yet inform HDL-C targets for stroke prevention; hypothesis-generating for BMI-mediated effects in Chinese cohorts.
BACKGROUND: Stroke has always been a huge medical challenge faced by China. Previous studies have found a negative correlation between high-density lipoprotein cholesterol (HDL-C) and stroke, but in recent years, with unsatisfactory drug experiments, researchers have begun to re-examine this relationship. Our research is based on the large population of middle-aged and elderly people in China, exploring the relationship between HDL-C and stroke and all-cause mortality. METHODS: The participants of this study were from the China Health and Retirement Longitudinal Study (CHARLS) database. We utilized univariate/multivariate logistic regression to screen the influencing factors of stroke. Using Cox regression, we calculated the hazard ratio (HR) for stroke and mortality, presenting our findings through Kaplan-Meier (KM) curves. We also presented the relationship between HDL-C and stroke and mortality by restricted cubic spline (RCS) regression analysis. A time-varying Cox analysis was conducted to evaluate the impact of changes in HDL-C on various outcomes. To strengthen the robustness and causal interpretation, we performed subgroup analysis, sensitivity analysis, and mediation pathway, and established a competing-risk model. RESULTS: HDL-C was negatively correlated with stroke. After adjusting for confounders, HDL-C remained a protective factor for stroke (HR 0.99, 95% CI 0.99-1.00, P < 0.05), especially in the male group, the normal BMI group, the group without dyslipidemia, and the group with hypertension in the subgroup analysis. However, no significant association was observed between HDL-C and all-cause mortality after adjustment (HR 1.00, 95% CI 1.00-1.01, p = 0.482). The results remained robust in sensitivity analysis and competitive risk models. The impact of HDL-C on the risk of stroke (HR 1.00, 95% CI 0.999-1.001, p = 0.887) and all-cause mortality (HR 1.00, 95% CI 0.9995-1.001, p = 0.539) did not show a significant trend over time. Mediation analysis revealed that BMI mediated 25% of the effect of HDL-C on stroke. CONCLUSIONS: In Chinese people over 45 years old, HDL-C was a protective factor for stroke, while it had no significant association with all-cause mortality. BMI mediated the effect of HDL-C on stroke. This research highlights the critical role of HDL-C in stroke risk assessment.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cohort in Stroke (n=6,090). High-density lipoprotein cholesterol (HDL-C) vs. Lower HDL-C levels was evaluated on Incident stroke (HR 0.99, 95% CI 0.99-1.00, p=<0.05). Higher HDL-C levels were independently associated with a reduced risk of stroke, with BMI mediating 25% of this protective effect.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: